Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BLINATUMOMAB vs BOCEPREVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BLINATUMOMAB vs BOCEPREVIR: Safety Overview

Metric BLINATUMOMAB BOCEPREVIR
Total FAERS Reports 9,161 2,078
Deaths Reported 1,664 112
Death Rate 18.2% 5.4%
Hospitalizations 2,427 478
Average Patient Age 39.7 yrs 53.1 yrs
% Female Patients 46.7% 44.4%
FDA Approval Date N/A May 13, 2011
Manufacturer Amgen, Inc N/A
Marketing Status Prescription Discontinued